BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2507782)

  • 1. Intra-abdominal adhesions and their prevention by topical tissue plasminogen activator.
    Menzies D; Ellis H
    J R Soc Med; 1989 Sep; 82(9):534-5. PubMed ID: 2507782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of postoperative adhesions by tissue-type plasminogen activator (t-PA) in the rabbit.
    Dörr PJ; Vemer HM; Brommer EJ; Willemsen WN; Veldhuizen RW; Rolland R
    Eur J Obstet Gynecol Reprod Biol; 1990 Dec; 37(3):287-91. PubMed ID: 2121563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of plasminogen activator in adhesion prevention.
    Menzies D; Ellis H
    Surg Gynecol Obstet; 1991 May; 172(5):362-6. PubMed ID: 1902993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant tissue plasminogen activator reduces adhesion formation in a rabbit uterine horn model.
    Doody KJ; Dunn RC; Buttram VC
    Fertil Steril; 1989 Mar; 51(3):509-12. PubMed ID: 2493405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of varying days of tissue plasminogen activator therapy on the prevention of postsurgical adhesions in a rabbit model.
    Dunn RC; Mohler M
    J Surg Res; 1993 Mar; 54(3):242-5. PubMed ID: 8474240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Keratinocyte Growth Factor Combined with a Sodium Hyaluronate Gel Inhibits Postoperative Intra-Abdominal Adhesions.
    Wei G; Zhou C; Wang G; Fan L; Wang K; Li X
    Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effect of intraperitoneally administered calcium channel blockade and recombinant tissue plasminogen activator to prevent adhesion formation in an animal model.
    Dunn RC; Steinleitner AJ; Lambert H
    Am J Obstet Gynecol; 1991 May; 164(5 Pt 1):1327-30. PubMed ID: 1903594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of experimental postoperative peritoneal adhesions through the intraperitoneal administration of tanshinone IIA.
    Wang C; Li X; Meng X; Zhou J; Qin F; Hou L
    Planta Med; 2014 Aug; 80(12):969-73. PubMed ID: 25089738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose dependency and wound healing aspects of the use of tissue plasminogen activator in the prevention of intra-abdominal adhesions.
    Evans DM; McAree K; Guyton DP; Hawkins N; Stakleff K
    Am J Surg; 1993 Feb; 165(2):229-32. PubMed ID: 8427402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of postsurgical adhesions in a standardized rabbit model: intraperitoneal treatment with tissue plasminogen activator.
    Orita H; Fukasawa M; Girgis W; diZerega GS
    Int J Fertil; 1991; 36(3):172-7. PubMed ID: 1678373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ability of recombinant tissue plasminogen activator to inhibit post-radical pelvic surgery adhesions in the dog model.
    Montz FJ; Fowler JM; Wolff AJ; Lacey SM; Mohler M
    Am J Obstet Gynecol; 1991 Nov; 165(5 Pt 1):1539-42. PubMed ID: 1957891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental adhesion prophylaxis with recombinant tissue plasminogen activator.
    Vipond MN; Whawell SA; Scott-Coombes DM; Thompson JN; Dudley HA
    Ann R Coll Surg Engl; 1994 Nov; 76(6):412-5. PubMed ID: 7702327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined effects of tissue plasminogen activator and carboxymethylcellulose on adhesion reformation in rabbits.
    Gehlbach DL; O'Hair KC; Parks AL; Rosa C
    Int J Fertil Menopausal Stud; 1994; 39(3):172-6. PubMed ID: 7920754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue-type plasminogen activator and adhesion prevention.
    Dunn RC
    Prog Clin Biol Res; 1993; 381():213-20. PubMed ID: 8316565
    [No Abstract]   [Full Text] [Related]  

  • 15. Statins (HMG-CoA reductase inhibitors) decrease postoperative adhesions by increasing peritoneal fibrinolytic activity.
    Aarons CB; Cohen PA; Gower A; Reed KL; Leeman SE; Stucchi AF; Becker JM
    Ann Surg; 2007 Feb; 245(2):176-84. PubMed ID: 17245169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical events in peritoneal tissue repair.
    diZerega GS
    Eur J Surg Suppl; 1997; (577):10-6. PubMed ID: 9076447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of postsurgical adhesions in a rat model: a comparative study.
    Irkorucu O; Ferahköşe Z; Memiş L; Ekinci O; Akin M
    Clinics (Sao Paulo); 2009; 64(2):143-8. PubMed ID: 19219320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of fibrinolysis in adhesion formation.
    Holmdahl L
    Eur J Surg Suppl; 1997; (577):24-31. PubMed ID: 9076449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of expression of tissue plasminogen activator and plasminogen activator inhibitor-1 by dichloroacetic acid in human fibroblasts from normal peritoneum and adhesions.
    Diamond MP; El-Hammady E; Wang R; Kruger M; Saed G
    Am J Obstet Gynecol; 2004 Apr; 190(4):926-34. PubMed ID: 15118614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chinese medicine compound Changtong oral liquid on postoperative intestinal adhesions.
    Yang XX; Shi HP; Hou LB
    World J Gastroenterol; 2005 May; 11(19):2967-70. PubMed ID: 15902738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.